The trademark application NLIVEN PR was filed by Sexton Biotechnologies, Inc., a U.S. corporation (the "Applicant"). The application was published for oppositions on January 4, 2018, and it was registered by office on April 12, 2018 without any oppositions.
The application was filed in Danish (English was selected as the second language).
Change of name and professional address of the trademark registration was recorded on December 10, 2018. A transfer of the trademark registration was recorded on July 19, 2021.